Sanguina: Fingernail Selfies as Iron Deficiency Test

The technology developed by Sanguina employs a unique algorithm to assess hemoglobin levels in blood by evaluating and interpreting the color present in the nail bed.
Founded by Dr. Wilbur Lam, Erika Tyburski, and Rob Mannino, the company originated from investigations performed at both the Georgia Institute of Technology and Emory University.
According to Dr. Lam, a clinical hematologist-bioengineer affiliated with the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta, as well as an associate professor of pediatrics at Emory University School of Medicine and a faculty member within the Wallace H. Coulter Department of Biomedical Engineering at Emory University and Georgia Tech, “This anemia detection method, which doesn’t require a needle, is the sole app-based solution with the capability to potentially substitute a standard blood analysis.”
To date, Sanguina has secured over $4.2 million in financial support through investments from The Seed Lab and XRC Labs, alongside grant funding received from The National Science Foundation and The National Institutes of Health, as stated in a company release.
Related Posts

LatAm Doctor Communication: Ex-Uber Eats Exec Raises $14M Seed

Chai Discovery Raises $130M Series B - AI Biotech Funding

Inito AI Antibodies: Expanding At-Home Fertility Testing

Brain Fitbit: Startup Tackles Chronic Stress with Wearable Tech

Max Hodak's New Venture: Beyond Neuralink
